FTC Loses Androgel Pay-For-Delay Appeal In 11th Circ.
The Eleventh Circuit on Wednesday axed the Federal Trade Commission's antitrust challenge to patent settlements Solvay Pharmaceuticals Inc. inked with several generics makers to protect its blockbuster drug Androgel, dealing another...To view the full article, register now.
Already a subscriber? Click here to view full article